GLP/GIP/Glucagon (10 Vials)

Description

Overview

GLP/GIP/Glucagon is a synthetic triple-agonist research peptide designed to activate GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor profile makes it a valuable tool for studying incretin biology, metabolic regulation, and complex peptide–receptor interactions in controlled research settings.

Researchers use GLP/GIP/Glucagon to investigate how coordinated signaling across these three pathways influences glucose metabolism, energy expenditure, lipid processing, and appetite-related mechanisms.

Product Details

• Purity: Research-grade, typically >99% (HPLC/MS verified)
• Status: Investigational peptide; not approved for therapeutic use
• Molecular Formula: C₂₉₄H₄₄₆N₇₈O₉₃S₂
• Molecular Weight: ~6,134 g/mol
• CAS Number: 2381089-83-2
• Synonyms: LY3437943, triple GIP/GLP-1/Glucagon receptor agonist

Research Applications

• Triple-Receptor Studies: For examining coordinated activation of GIP, GLP-1, and glucagon receptors in metabolic pathways.
• Metabolic Regulation Research: Supports studies on glucose utilization, lipid metabolism, and energy balance.
• Body Composition Modeling: Used to explore appetite signaling, nutrient handling, and metabolic adaptation.
• Peptide Engineering & Stability: Serves as a reference for peptide optimization, bioactivity, and formulation development.

Usage & Safety

For laboratory research use only. Not approved for human or veterinary use and not for diagnostic or therapeutic purposes. Handle according to standard laboratory safety procedures.

Disclaimer

All information is provided for scientific and educational research purposes only. This material is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.